C. elegans is a valuable model organism that is widely used in the study of gene function and complex molecular processes. Recently, C. elegans has become a powerful tool for drug screening due to genetic and molecular ease of handling, adaptability of high-throughput screening methods, and cost-effectiveness of experiments. At CD BioSciences, we utilize C. elegans high-throughput screening platforms, advanced imaging platforms, and data analysis software to provide drug screening services for our global clients, including anti-infective compounds, anti-neurodegenerative disease drugs, longevity compounds, and anti-cancer drugs. In addition, we also offer customized pipelines to identify drug targets and mechanisms for the particular needs of our customers.

Advantages of C. elegans in Drug Screening

Drug development is a long, complex, and expensive process, especially in the early stages of drug screening, and requires a large number of low-cost and time-consuming animal models. As a model organism, C. elegans has been used for the study of fundamental biological processes such as apoptosis, senescence, and regulation of gene expression. With the emergence of large-scale screening platforms, C. elegans has become an important tool for the drug research industry to identify new drugs and drug targets, as well as an invaluable tool for screening compounds with potential therapeutic uses. C. elegans has the following advantages when used for drug screening:

Fig.1 Caenorhabditis elegans as a versatile platform for drug discovery. (Giunti S, et al., 2021)

Our Services

The C. elegans disease model not only facilitates researchers' understanding of the disease, but also accelerates the screening of drugs for neurodegenerative diseases, anti-infective compounds, and anti-cancer drugs. As an expert in C. elegans research, CD BioSciences is committed to providing you with drug screening services utilizing high-throughput screening platforms to help you break through the difficulties in your drug screening programs. The C. elegans drug screening services we provide include but are not limited to:

Workflow of Our Services

Why Choose CD BioSciences?

As the world's leading custom service provider, we are dedicated to accelerating the speed to achieve customers' research goals with high-quality, and also provide the customized service to suit the particular needs of customers' research. If you are interested in our service, please feel free to contact us for more information.

Reference

1. Giunti S, Andersen N, Rayes D, et al. Drug discovery: Insights from the invertebrate Caenorhabditis elegans[J]. Pharmacology Research & Perspectives, 2021, 9(2): e00721.

Related Services

• C. elegans Genetic Engineering Service
• C. elegans RNAi Service
• C. elegans Mutagenesis Service
• Other Services
• C. elegans Phenotype Analysis Service
• C. elegans Stress Analysis Service
• C. elegans Omics Service
• C. elegans Disease Model Construction Service
• Probiotics Screening Service
• Neurological Disease Drug Screening Service
• Anti-infective Compound Screening Service
• Pro-longevity Compound Screening Service
• Anti-cancer Drug Screening Service